Most Read Articles
Audrey Abella, 12 Jan 2021
Long-term betibeglogene autotemcel (beti-cel) gene therapy led to durable, stable responses in patients with transfusion-dependent β-thalassaemia (TDT), according to two studies presented at ASH 2020.
14 Dec 2020
A prescription of nonvitamin K antagonist (VKA) oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) leads to a lower renal function worsening compared to those receiving VKAs, suggests a recent study, adding that such effect is partially lost in diabetic patients.
18 Sep 2020
Use of nonvitamin K antagonist oral anticoagulants (NOACs), particularly dabigatran, is associated with a significantly reduced risk of laboratory-based liver injury among patients with atrial fibrillation (AF) when compared with warfarin, results of a recent study have shown.
Roshini Claire Anthony, 18 Jan 2021

Roxadustat appears a promising treatment for anaemia in patients with chronic kidney disease (CKD), regardless of whether they are undergoing dialysis, according to two analyses presented at ASH 2020.

Product Highlight - FLUIMUCIL

17 Dec 2020
  • Acetylcysteine, active ingredient of FLUIMUCIL, exerts an intensive mucolytic-fluidifying action on mucous and mucopurulent secretions by depolymerizing the mucoproteic complexes and the nucleic acids which confer viscosity to the vitreous and purulent component of the sputum and other secretions.
  • Acetylcysteine (FLUIMUCIL) is suitable for the treatment of acute and chronic affections of the respiratory system, characterized by thick, viscous mucous and mucopurulent secretions.
  • Acetylcysteine is a specific antidote in paracetamol poisoning and during treatment with cyclophosphamide induced hemorrhagic cystitis.

Reference:
https://www.cathaydrug.com/product/fluimucil

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 12 Jan 2021
Long-term betibeglogene autotemcel (beti-cel) gene therapy led to durable, stable responses in patients with transfusion-dependent β-thalassaemia (TDT), according to two studies presented at ASH 2020.
14 Dec 2020
A prescription of nonvitamin K antagonist (VKA) oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) leads to a lower renal function worsening compared to those receiving VKAs, suggests a recent study, adding that such effect is partially lost in diabetic patients.
18 Sep 2020
Use of nonvitamin K antagonist oral anticoagulants (NOACs), particularly dabigatran, is associated with a significantly reduced risk of laboratory-based liver injury among patients with atrial fibrillation (AF) when compared with warfarin, results of a recent study have shown.
Roshini Claire Anthony, 18 Jan 2021

Roxadustat appears a promising treatment for anaemia in patients with chronic kidney disease (CKD), regardless of whether they are undergoing dialysis, according to two analyses presented at ASH 2020.